IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

about

SERPING1 mRNA overexpression in monocytes from HIV+ patients.

P2860

Q40049100-83A413CE-2FAF-416B-8D36-BFC20F762EC6

P2860

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

Item

http://www.wikidata.org/entity/Q38720858

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

@en

type

Item

label

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

@en

prefLabel

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

@en

P1476

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

@en

P2093

Douglas F Nixon

http://www.w3.org/2001/XMLSchema#string

Greta A Beckerle

http://www.w3.org/2001/XMLSchema#string

Paul M Zdinak

http://www.w3.org/2001/XMLSchema#string

Phillip M Brailey

http://www.w3.org/2001/XMLSchema#string

Richard B Jones

http://www.w3.org/2001/XMLSchema#string

Rui André Saraiva Raposo

http://www.w3.org/2001/XMLSchema#string

Szu-Han Huang

http://www.w3.org/2001/XMLSchema#string

Vinicius D Cabido

http://www.w3.org/2001/XMLSchema#string

P2860

TRIM5 is an innate immune sensor for the retrovirus capsid lattice

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

The IFITM proteins inhibit HIV-1 infection

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Intrinsic host restrictions to HIV-1 and mechanisms of viral escape.

Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.

Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

P304

e85811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI.INSIGHT.85811

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Miguel de Mulder Rougvie

Dominic Paquin Proulx

Allison S Thomas

P577

2017-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097226

http://www.w3.org/2001/XMLSchema#string

P932

5214598

http://www.w3.org/2001/XMLSchema#string

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

about

P2860

P2860

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932